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Abstract
The most common cause of amyotrophic lateral sclerosis (ALS) and
frontotemporal dementia (FTD) is an intronic hexanucleotide
repeat expansion in the C9orf72 gene. In disease, RNA transcripts
containing this expanded region undergo repeat-associated nonAUG translation to produce dipeptide repeat proteins (DPRs),
which are detected in brain and spinal cord of patients and are
neurotoxic both in vitro and in vivo paradigms. We reveal here a
novel pathogenic mechanism for the most abundantly detected
DPR in ALS/FTD autopsy tissues, poly-glycine-alanine (GA). Previously, we showed motor dysfunction in a GA mouse model without
loss of motor neurons. Here, we demonstrate that mobile GA
aggregates are present within neurites, evoke a reduction in
synaptic vesicle-associated protein 2 (SV2), and alter Ca2+ influx
and synaptic vesicle release. These phenotypes could be corrected
by restoring SV2 levels. In GA mice, loss of SV2 was observed without reduction of motor neuron number. Notably, reduction in SV2
was seen in cortical and motor neurons derived from patient
induced pluripotent stem cell lines, suggesting synaptic alterations
also occur in patients.
Keywords amyotrophic lateral sclerosis; C9orf72; dipeptide repeat proteins;
motor deficit; synaptic transmission
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Introduction
An intronic hexanucleotide repeat expansion (GGGGCC)n in the
C9orf72 gene is the most frequent genetic cause of amyotrophic

lateral sclerosis (ALS) and frontotemporal dementia (FTD)
(Couthouis et al, 2011; DeJesus-Hernandez et al, 2011; Renton et al,
2011). Evidence has been produced in support of three pathogenic
mechanisms linked to this disease-causing expansion: (i) a loss-offunction mechanism due to decreased levels of C9orf72 mRNA
expression (Ciura et al, 2013; Therrien et al, 2013; Shi et al, 2018);
(ii) RNA transcripts generated from the expanded region gain toxic
functions either by forming RNA–DNA hybrids that inhibit transcription and/or by sequestering RNA-binding proteins in nuclear
foci (Gendron et al, 2013; Gitler & Tsuiji, 2016); (iii) through repeatassociated non-AUG translation, expanded RNA transcripts encode
six dipeptide repeat (DPR) proteins (sense: poly-glycine-alanine or
GA, poly-glycine-arginine or GR, poly-glycine-proline or GP; antisense: poly-proline-arginine or PR, poly-proline-alanine or PA, and
poly-proline-glycine or PG), which display different toxic profiles in
different organismal and cell culture systems (Ash et al, 2013; Mori
et al, 2013; Zu et al, 2013; Mizielinska et al, 2014; Haeusler et al,
2016; Wen et al, 2017). Each of these mechanisms invokes widespread cellular responses and, in some cases, culminates in
neuronal toxicity and cognitive and motor dysfunctions resembling
the human disease phenotype (Kwon et al, 2014; Mizielinska et al,
2014; Wen et al, 2014, 2017; Tao et al, 2015).
Evidence is mounting for dysfunctional neuromuscular junction
(NMJ) transmission as an early event in C9orf72-ALS (Sareen et al,
2013; Devlin et al, 2015). Notably, two independent studies in
Drosophila melanogaster larvae have investigated structural attributes of the NMJ in animals expressing GGGGCC repeats. In these
studies, both groups reported drastic reductions in the number of
NMJ active zones in larvae expressing 30 or more GGGGCC repeats
(Freibaum et al, 2015; Zhang et al, 2015). Detailed analysis also
revealed a significant decrease in synaptic bouton number (Freibaum et al, 2015), as well as reduced synaptic quantal content leading to attenuated evoked potentials (Zhang et al, 2015). However, it
is not clear whether these effects are due to toxic gain of function of
expanded RNA transcripts, DPRs, or a combination of both acting

1 Jefferson Weinberg ALS Center, Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, USA
2 German Center for Neurodegenerative Diseases (DZNE), Munich, Germany
3 Department of Neuroscience, Vickie and Jack Farber Institute for Neuroscience, Thomas Jefferson University, Philadelphia, PA, USA
*Corresponding author. Tel: +1 215 955 8416; E-mail: davide.trotti@jefferson.edu

© 2020 The Authors. Published under the terms of the CC BY 4.0 license

EMBO Molecular Medicine

12: e10722 | 2020

1 of 26

EMBO Molecular Medicine

synergistically. Based on numerous recent reports investigating
these potential pathogenic mechanisms both in vitro and in animal
models, a substantial focus has now been placed on better investigating the effects of DPRs and their potential pathogenic consequences (Gitler & Tsuiji, 2016; Freibaum & Taylor, 2017; Wen et al,
2017). As such, herein we have chosen to limit our mechanistic
analysis regarding C9orf72 repeat expansion effects on synaptic
function to the contribution of DPR-mediated pathological changes,
in the absence of potential confounds due to the concomitant presence of GGGGCC repeat-containing RNA transcripts.
Abundant evidence for in vivo and in vitro effects of DPRs has
amassed, pointing to pathogenic roles for these dipeptides (Kwon
et al, 2014; Mizielinska et al, 2014; Wen et al, 2014; Tao et al,
2015; Boeynaems et al, 2016; Schludi et al, 2017). In fly models as
well as primary neurons, arginine-containing DPRs (GR and PR)
evoke the most robust toxicity (Mizielinska et al, 2014; Wen et al,
2014; Boeynaems et al, 2016). GR and PR both form aggregates in
the nucleus and result in a host of cellular abnormalities including
nuclear transport defects, protein mislocalization, altered RNA
processing, and nucleolar stress (Kwon et al, 2014; Tao et al, 2015;
Kim & Taylor, 2017). While not as overtly toxic, GA also contributes
to neuronal dysfunction through ER stress, proteasome impairment,
and sequestration of Unc119, HR23, and nucleocytoplasmic transport proteins (May et al, 2014; Zhang et al, 2016). In contrast,
marginal or no toxic effects have been attributed to PA and GP/PG
(Zu et al, 2013; Wen et al, 2014).
While DPR inclusions have been detected throughout the CNS of
C9orf72-ALS/FTD patients, the most widespread and abundantly
observed are GA+ inclusions (Ash et al, 2013; Gendron et al, 2013;
Mori et al, 2013; Zu et al, 2013). In contrast to the robust toxicity
resulting from expression of the arginine-rich DPRs, cellular impairments mediated by GA appear to be more subtle. Two mouse
models have independently demonstrated motor deficits stemming
from neuronal GA expression by 6 months of age. When confined
to the cortex, GA50 aggregates lead to neuronal loss, brain atrophy,
and mild motor and cognitive behavioral deficits (Liu et al, 2016),
whereas when expressed in spinal cord and brainstem, aggregates
positive for GA149 trigger significant motor deficits in the absence of
overt neuronal loss (Schludi et al, 2017). From this study, our findings suggest that in motor neurons in vivo, GA-mediated synaptic
deficits may precede cell death (Schludi et al, 2017). This possibility
highlights the necessity for a deeper investigation of subcellular
repercussions in neurons coping with expression and aggregation of
GA dipeptides, in order to identify mechanisms that may be targeted
in a therapeutic window before cell death.
We and others have previously demonstrated that GA expression
in primary neurons results in reduced neurite outgrowth and cellular toxicity through proteasome impairment and ER stress (May
et al, 2014; Zhang et al, 2014). However, the consequences of GA
inclusions on neuronal signaling have not yet been examined. In the
present study, we have demonstrated that GA aggregates are mobile
within axonal and dendritic neuronal compartments. These GA
aggregate expressing neurons display disrupted Ca2+ influx, selective down-regulation of the synaptic vesicle-associated protein 2
(SV2), ablated synaptic release, and increased risk of death.
Through immunoblot analysis of spinal cords and synaptic staining
at neuromuscular junctions from GA149 transgenic mice, which
displayed abnormal gait and progressive balance impairment but no
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appreciable neuronal loss, we have confirmed the selective loss of
SV2 expression. Furthermore, we have extended our findings to
patient-derived cells, where the full complement of C9orf72 repeat
expansion pathogenic mechanisms are potentially at play. In
induced pluripotent stem cells differentiated into cortical or motor
neurons, neurons derived from C9orf72 repeat expansion carriers
again displayed specific reduction of SV2 levels compared with
control cells. These in vivo and patient-derived validations of our
findings suggest that this molecular phenotype could underlie or
contribute to the prodromal progression of disease symptoms. Most
crucially, we have been able to restore synaptic function and rescue
cellular toxicity through targeted upregulation of SV2 in GA-expressing primary neurons. These findings suggest that GA-mediated
alterations of SV2 levels and localization are reversible processes,
from which neurons can convalesce, even under the continued presence of GA aggregates.

Results
GA inclusions are found in axons and dendrites of neurons
Immature primary cortical neurons (DIV4) expressing GA149-myc
displayed reduced dendritic complexity and sign of apoptosis (May
et al, 2014). Nevertheless, in an extensive GA repeat length
response curve in mature primary cortical (transfected at 7 DIV) and
motor neurons (transfected at 5 DIV), we did not observe significant
toxicity at any GA length up to 400 repeats, at 7 or 3 days posttransfection, respectively (Wen et al, 2014). We have also noted in
the animal model of GA149-CFP expression that these mice developed behavioral and motor abnormalities, such as abnormal gait
and progressive balance impairment in the absence of neuronal loss
(Schludi et al, 2017), suggesting dysfunctional neuronal activity.
We and others have established that when expressed in a variety
of cell lines and in primary rodent neurons, GA forms dense cytosolic aggregates (May et al, 2014; Wen et al, 2014; Zhang et al, 2014).
Indeed even when transmitted from cell to cell, GA maintains the
tendency for cytosolic accumulation and aggregation (Chang et al,
2016; Westergard et al, 2016). As post-mitotic neurons have distinctive morphology and complex axonal and dendritic arborization
architectures, in our prior work we also examined GA-expressing
neurons at high spatial resolution (Wen et al, 2014). Mature cortical
and motor neurons expressing GA50 (eGFP-tagged) were counterstained with neuronal marker SMI-32. Intriguingly, in addition to
cytoplasmic aggregates in the cell soma, eGFP-GA inclusions were
also present within neurites (Wen et al, 2014). This localization
pattern was unique to the GA dipeptide as we did not observe any
of the other dipeptides within neuritic processes (Wen et al, 2014).
To begin this present work, in order to determine whether poly-GA
aggregates are found in neurites over time, we performed a longitudinal assessment of aggregates, in which GA50 was expressed in
mature cortical neurons, with fixation and staining on subpopulations of cells at specific time points. Cells were counterstained with
SMI-32. At all time points examined (2, 4, or 8 days of expression),
distinctive eGFP+ GA aggregates could be found in neuritic regions
(Fig 1). We confirmed that even following 8 days of expression,
GFP alone without associated GA peptides does not induce GFP
aggregation. Diffuse, cell-filling GFP expression can still be seen in
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Figure 1. GA50 aggregates are detected in neurites of cortical neurons over time.
Primary rat cortical neurons transfected with eGFP-GA50 were examined to determine at which time points preceding cell-death aggregates are found in neurites. Two days
post-transfection, aggregates formed by eGFP-GA50 (green) are detectable in neurites (SMI-32 staining in red). These aggregates remain localized to neurites at 96 h (4 days)
and 288 h (8 days). Colocalization is indicated by yellow overlay of colors (right panels). Inset below each image shows enlargement of neurite regions containing
aggregates, representative fields from 60× magnification z-stack confocal images, scale bar indicates 20 lm. Inset scale bars indicate 5 lm.
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control cells at 8 days of eGFP expression (Fig EV1A). Quantification of the percentage of GA aggregate containing cells displaying neuritic aggregates revealed that at 2 days of expression
66.93%  5.57% of cortical GA-expressing neurons have aggregates
in their neurites. Comparably, an identical transfection of mature
motor neurons revealed that 55.62%  6.70% of GA-expressing
motor neurons contain neuritic aggregates at 2 days of expression.
Next, we wanted to determine the stability of GA aggregates over
time. Mature cortical neurons (DIV10) were co-transfected with
eGFP, or eGFP-GA50 and a synapsin promoter-driven Td-tomato
cell-filling reporter. After 24 h, transfected neurons were identified
by co-positivity of eGFP and td-Tomato. The same neurons were
then visualized every 24 h for 8 days. We observed that GA inclusions could be cleared over time by the neurons in which they have
formed (Fig EV1B).
GA aggregates are mobile within neurites
The presence of dynamic GA aggregates within neurons suggested
additional possible deleterious consequences specific to neuronal
cell lineages, including altered cellular trafficking of proteins and
organelles to synaptic terminals, as well as dysfunctional synaptic
transmission. To probe into these questions, we employed a variety of live-cell imaging functional assays and confocal imaging
assessment of synaptic-associated proteins involved in neurotransmission.
Using high-resolution live-cell imaging to monitor trafficking of
different cargoes within neurites, we first assessed whether the GA
aggregates themselves were mobile or stationary, and whether the
length of the GA repeat would be a determinant for such mobility.
GA at different lengths was transfected into mature cortical or
motor neurons at DIV7 and DIV5, respectively. The length range of
eGFP-GAn utilized for our current experiments spanned from 25 to
400 repeats as previously described (Wen et al, 2014). The
sequences for these constructs were designed following a randomized codon strategy to generate the specified poly-dipeptide
sequence of the designated repeat length, but to avoid GGGGCC
repeat expansions in the corresponding RNA transcripts (Wen
et al, 2014). Brightfield image overlay with the eGFP channel
clearly shows distinct GA aggregates within neuritic regions of
both cell populations (Fig 2A and B). Following 48 h of expression, high-resolution 60× images were taken at a rapid frame rate,
allowing the position of individual eGFP+ GA particles to be
tracked over time (NIH ImageJ software). In cortical neurons,
aggregates of short GA repeat lengths (25–50) displayed higher
mobility along neurites, while aggregates from longer GA repeats
(100–400) were more stationary (**P < 0.01; Fig 2C). Similarly, a
repeat length-dependent effect on GA particle velocity was
observed in primary motor neurons (****P < 0.0001; Fig 2D). We
next evaluated whether the presence of neuritic GA aggregates
constituted an impediment to the normal trafficking of organelle
cargoes along microtubules. To do so, we transfected cultures with
eGFP-GAn repeats at increasing lengths and subsequently labeled
mitochondria with the cell-permeable dye MitoTracker Deep Red,
lysosomes with the cell-permeable dye Lysotracker Deep Red, or
total RNA with SYTO RNASelect green. eGFP+ neurons were identified, and mitochondria visualized using the 637-laser channel
suitable for the excitation spectrum of the MitoTracker dye.
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Representative images from cortical neurons demonstrate neuritic
eGFP-GA aggregates and distinct mitochondrial labeling with the
MitoTracker dye (Fig EV2A). In a similar fashion, eGFP+ neurons
were identified, and lysosomes visualized using the 637-laser channel suitable for the excitation spectrum of the Lysotracker dye.
Representative images from cortical neurons demonstrate neuritic
eGFP-GA aggregates and distinct lysosomal labeling (Fig EV2B). In
contrast to the GA aggregates themselves, mitochondrial mobility
was unaffected by the presence of GA inclusions within neurites.
Mitochondrial mobility was compared across the GA length curve
as well as with a GFP-only expressing control, showing no changes
at 48 h in cortical neurons (Fig EV2C) or motor neurons
(Fig EV2D). Performing the same analysis of lysosomal mobility
revealed that only GA400 containing cortical neurons displayed a
significant reduction in mobility (*P < 0.01; Fig EV2E). We also
assessed the mobility of total cellular RNA through the use of
SYTO RNASelect dye labeling in mCherry control or mCherry-GA50
expressing cortical neurons (Fig EV2F). Upon analysis, we again
discovered no deficits in overall RNA mobility in GA-expressing
cells. We have therefore established that GA aggregates move
along cortical and motor neuron processes, without significantly
impacting the kinetics of transport of cargoes vital for cell survival.
GA-containing neurons display slow toxicity
We wanted to verify that these in vitro reported phenotypes were
the result of GA-dependent mechanisms intrinsic to neurons, rather
than a secondary phenomenon that is occurring in cells that are
already committed to die following GA expression.
As such, we investigated the longitudinal survival of GA-expressing neurons. Mature cortical neurons (DIV7) or motor neurons
(DIV5) were co-transfected with eGFP, eGFP-GA50 or eGFP-GA100,
and a synapsin promoter-driven Td-tomato cell-filling reporter.
After 24 h, transfected neurons were identified by co-positivity of
eGFP and td-Tomato. The same neurons were then visualized
every 24 h for an additional 13 days (cortical neurons) and
10 days (motor neurons). Expression of either GA50 or GA100
resulted in statistically significant decreased percent survival only
at 13 days post-transfection (DIV23) (Fig 3A and B) and motor
neuron survival at 10 days post-transfection (DIV15) (Fig 3C)
compared with GFP-only expressing neurons. This translates in
progressive loss of neurons over time, which can be clearly seen
in representative images (marked with white arrows), and was
confirmed by Kaplan–Meier survival curve analysis and log-rank
testing of hundreds of neurons compiled over multiple independent
experiments (****P < 0.0001; Fig 3). Hazard ratios at day 13 in
cortical neurons revealed an increased hazard of death in both
GA50 (1.677) and GA100 (1.263) conditions. Similarly, hazard ratios
at day 10 in motor neurons revealed an increased hazard of death
with both GA lengths of 1.345 and 1.736, respectively. While we
observed a length-associated increase in toxicity in motor neurons,
this was not the case in cortical neurons. We infer that this is due
to the high burden and mobility of GA50 aggregates in these cells.
Therefore, the GA-induced cell death we observe occurs much later
than the time frame in which we demonstrate mobile neuritic
aggregates (2 days post-transfection). This suggests a window of
time in which these aggregates have the potential to influence
normal neuronal function.
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Figure 2. Aggregates from short GA25-50 repeat lengths are mobile, while those from longer repeats are more stationary.
Primary rat cortical and motor neurons underwent live-cell imaging after 48 h of eGFP-GAn expression to determine aggregate mobility within neurites.
A Example of a cortical neuron-expressing eGFP-GA100 (green) with brightfield overlay, 60× magnification, scale bar indicates 10 lm. Inset in upper right shows
enlargement of boxed area, to better visualize aggregates within neuronal processes. Inset scale bar indicates 5 lm.
B Example of a motor neuron expressing eGFP-GA25 (green) with brightfield overlay, 60× magnification, scale bar indicates 10 lm. Inset in upper right shows
enlargement of boxed area, to better visualize aggregates within neuronal processes. Inset scale bar indicates 5 lm.
C Quantification of eGFP-GAn aggregate velocity within cortical neuron neurites.
D Quantification of eGFP-GAn aggregate velocity within motor neuron neurites.
Data information: Data presented as mean  SEM. One-way ANOVA, post hoc Dunnett’s multiple comparison test, **P < 0.01, ****P < 0.0001. Exact P-values can be
found in Appendix Table S1. Velocity measurements from 10 aggregates were assessed from each of three biological replicates for each GA repeat length in each
neuronal population.
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6 of 26

EMBO Molecular Medicine 12: e10722 | 2020

ª 2020 The Authors

Brigid K Jensen et al

◀

EMBO Molecular Medicine

Figure 3. Poly-GA-containing neurons display delayed cell-death profile.
Primary rat neurons were co-transfected with Td-tomato and eGFP-GAn plasmids or eGFP alone. The same neurons were imaged at 24-h intervals to assess viability.
A Representative fields (right) of eGFP and eGFP-GA50 cortical neurons at days 1, 7, and 13 post-transfection follow the survival of individual cells over time (white
arrows). 20× magnification, scale bar indicates 25 lm.
B Kaplan–Meier survival analysis of cortical neurons followed for 13 days post-transfection.
C Kaplan–Meier survival analysis of motor neurons followed for 5 days post-transfection.
Data information: Statistical analysis performed by Cox-proportional hazards ration and Mantel–Cox log-rank tests. Tables showing neuron number (#), hazard ratio
(HR), Cox-proportional hazards P-value (P), confidence interval (95% CI), and log-rank P-value (LRp) are shown to the right of each Kaplan Meier curve. At least 600 cells
per condition were evaluated from a pooling of n = 6 independent experiments, ****P < 0.0001. Exact P-values can be found in Appendix–Table S1.

Synaptic release is compromised in neurons containing
GA aggregates
A plausible outcome of GA inclusions within dendrites and axons is
disturbance in synaptic neurotransmission. To assess the functional
consequences of GA aggregates within neuronal processes, we
resorted to live-cell imaging and stimulation paradigms to assess
synaptic release and the length curve of eGFP-GAn constructs
coupled with the cell-permeable dye FM4-64. After 48 h of eGFPGAn expression, cells were loaded with this dye, which accumulates
in synaptic vesicles and can be used as a readout for vesicle exocytosis (Gaffield & Betz, 2006; Verstreken et al, 2008) (Fig 4A). eGFP+
cells were identified, and 10 synaptic puncta loaded with FM4-64
per region of interest per cell were monitored. Baseline measurements were acquired, followed by perfusion with high K+ ACSF
solution to induce synaptic firing and dye unloading (Fig 4B). Kinetics are presented as change (loss) in fluorescence (DF) over basal
fluorescence (F), DF/F. A representative graph shows eGFP-GA50
compared with eGFP expressing neurons over the course of stimulation (Fig 4C). Evaluation of cortical neurons expressing GA peptides
revealed a striking abrogation of synaptic vesicle release. Compared
to eGFP alone, which reduced fluorescence signal to 74.7%  3.3%
of pre-stimulation levels, all of the GA lengths significantly impaired
FM4-64 dye release (GA25: 94.5%  1.6%, GA50: 103.1%  1.7%,
GA100: 97.4%  2.8%, GA200: 94.1%  2.5%, GA400: 99.6% 
0.5%) (***P < 0.001). Furthermore, as analyzed by non-linear
regression based on the plateau followed by one-phase decay model,
there was a significant reduction in decay rate for cells containing
GA aggregates. While the decay constant (k) for eGFP cells during
stimulation was 0.497 s1, this was dramatically increased to
219.5 s1 in GA50 containing cells. These results indicate that
signals for neuronal firing are not being effectively executed in GAcontaining cells; however, we could not yet rule out whether this
was based on ineffective signaling or faults in synaptic release.
Neurons with GA aggregates display increased Ca2+ influx
It is well established that when sufficient depolarization occurs to
trigger an action potential in a neuron, Ca2+ influx is required for
appropriate fusion of synaptic vesicles and release of neurotransmitter (Schneggenburger & Rosenmund, 2015). To determine whether
the failure of synaptic unloading we observed in GA-containing cells
was a result of altered Ca2+ entry, a live-cell imaging paradigm was
employed whereby mCherry-tagged GA constructs were co-transfected with a GCaMP Ca2+ indicator. After 48 h of expression,
co-transfected cells were selected for imaging based on dual
mCherry and GCaMP signal (Fig 5A). Following basal GCaMP
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fluorescence recording, neurons were perfused with high K+ ACSF
solution containing Ca2+ (1.33 mM) to trigger neuronal depolarization. A robust surge in intracellular Ca2+ signal was recorded
following such stimulation (Fig 5A). Quantification of the maximum
change in GCaMP fluorescence intensity over baseline was determined for each stimulated cell and compiled for 20 cells per condition. In both cortical and motor neurons, a significant increase in
intracellular Ca2+ signal was observed in mCherry-GA50 containing
cells compared with control mCherry-only expressing cells
(*P < 0.05, **P < 0.01; Fig 5B and C). We next sought to determine
whether there was a GA length dependence to this increased Ca2+
signal. Each of the GA length curve set of constructs was co-transfected with our GCaMP reporter construct. Following quantification
of the maximum change in GCaMP fluorescence intensity over baseline for this series, we determined that while the GA lengths each
produced significant increases in Ca2+ influx, they did not significantly differ among themselves in the magnitude of this change
(Fig EV3A). To determine whether the increased fluorescence signal
was due to Ca2+ influx into the neurons, stimulation of cells was
performed in high K+ ACSF that lacked free Ca2+. In these conditions, no significant difference between control mCherry and
mCherry-GA50 containing cells was found, indicating that extracellular Ca2+ entering into the cell was indeed responsible for the Ca2+
surge inside the neurons (Fig 5B and C). Thus, in contrast to our
expectations based on depressed synaptic unloading, we have found
a significant increase in Ca2+ influx in both cortical and motor
neurons expressing GA dipeptides.
Synaptic vesicle-associated protein 2 (SV2) is reduced in GAexpressing neurons in vitro
The aberrant increased Ca2+ influx in GA-expressing neurons
prompted us to examine whether synaptic proteins were being
affected, as altered Ca2+ homeostasis and signaling may have
dramatic implications for synaptic release and vesicle fusion events
(Zundorf & Reiser, 2011; Schneggenburger & Rosenmund, 2015).
We investigated whether the levels of synaptic vesicle component
proteins as well as neuritic morphology in our cortical and motor
neuron in vitro paradigms were affected by the expression of eGFPGAn. The three proteins chosen for our initial exploration, synaptophysin, synaptic vesicle-associated protein 2 (SV2), and PSD-95, all
serve vital purposes in synaptic transmission. SV2 is a crucial
component of active zones and synaptic release machinery, as it
forms complexes with other vesicle components synaptophysin,
synaptotagmin, and synaptobrevin (Mutch et al, 2011; Kwon &
Chapman, 2012; Li & Kavalali, 2017). While 3 isoforms of SV2 are
encoded in the human genome, SV2a is the most widely distributed
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Figure 4. GA aggregates significantly impair synaptic unloading.
Cortical neurons were loaded with FM4-64 dye 48 h after transfection. Basal fluorescence was monitored prior to induced depolarization via perfusion with ACSF containing
50 mM KCl.
A Representative dye loading showing defined puncta regions along neurites 40× magnification, scale bar indicates 10 lm.
B Representative intensities of FM4-64 puncta regions pre- and post-stimulation demonstrate loss of synaptic puncta fluorescence intensity following stimulation in
eGFP but not GA50 containing neurons. These images visually reflect the process performed in an automated manner through our imaging software to determine
puncta fluorescence intensity. An unbiased constant threshold is placed on each image per experiment; then fluorescence intensity is measured over time. The
threshold applied isolates puncta from background, giving distinct regions. 8-bit images were thresholded and pseudo-color (red) was applied to enlarged puncta
regions of interest, scale bar indicates 10 lm.
C Graphical representation is the change in fluorescence (DF) normalized to basal fluorescence (F), DF/F. The final 10 s of baseline recording and 10 s of the
depolarization phase are shown; arrow indicates start of depolarization. Non-linear regression was performed in GraphPad Prism7 using the plateau followed by onephase decay model. The decay constant (k) for eGFP was 0.4971 s1, while for GA50, it was 219.5 s1. Similarly, the tau (s) values were 2.012 s for eGFP and 0.00455 s
for GA50, respectively. Data presented as mean  SEM for each imaged timepoint. Statistical significance was determined using the Sidak–Bonferroni method,
****P < 0.0001, n = 20 puncta regions from four biological replicates. Exact P-values can be found in Appendix Table S1.
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Figure 5. Ca2+ influx is increased in neurons containing GA aggregates.
Primary cortical or motor neurons were co-transfected with mCherry or mCherry-GA50 and GCaMP6f. After 48 h, mCherry-positive cells were determined. Green
fluorescence intensity was then recorded from identified neurons. Basal fluorescence was monitored prior to induced depolarization via perfusion with ACSF containing
50 mM KCl.
Representative images of a co-transfected cortical neuron expressing mCherry-GA50 (left panel) and GCaMP6f (right two panels). This image shows a representative
demonstration of the increase in detectable green fluorescence from the GCaMP6f indicator pre- and post-stimulation (center and right, respectively). 40×
magnification, scale bar indicates 25 lm.
B, C Graphical representation of the peak change in fluorescence (DF) following ACSF perfusion normalized to basal fluorescence (F), DF/F. The contribution of Ca2+
influx was determined by experiments in which stimulation was performed in ACSF containing high KCl but no Ca2+. Quantification of the peak change in
fluorescence in cortical neurons (B) and motor neurons (C).

A

Data information: Data presented as mean  SEM. One-way ANOVA with uncorrected Fisher’s LSD test, *P < 0.05, **P < 0.01. A total of 20 cells per condition were
pooled from eight independent experiments. Exact P-values can be found in Appendix Table S1.
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in the brain and is the target of several pharmaceutical compounds
(Crevecoeur et al, 2013). This isoform has been the focus of our
experiments, and will be referred to as simply SV2 throughout this
article. SV2 is also speculated to be a transport protein for neurotransmitter import into synaptic vesicles (Feany et al, 1992) and
plays an integral role in maintaining appropriate machinery for
Ca2+ entry at synapses through interactions with voltage-gated Ca2+
channels (Vogl et al, 2015). Additionally, through association with
laminin and laminin-related proteins, SV2 specifically participates in
synapse re-innervation (Son et al, 2000; Singhal & Martin, 2011).
Synaptophysin is also a crucial component of synaptic vesicles and
one of the most abundant proteins, making up 8% of total vesicle
content (Evans & Cousin, 2005). Instead of facilitating evoked
neurotransmitter release, synaptophysin is believed to play a role in
vesicular recycling (Evans & Cousin, 2005). An equally important
region to evaluate is the postsynaptic density, as this is where signal
transduction events are relayed. PSD-95 is a key structural component of the postsynaptic density and serves as our marker of potential changes in this cellular region. It is thought that PSD-95 plays a
role in the organization of the postsynaptic density, through binding
of constituent proteins like AMPA receptors, NMDA receptors, adhesion molecules, and other scaffolding proteins (Chen et al, 2011).
Mature cortical and motor neurons were transfected with our eGFPGAn construct at different lengths and immunostained for these
synaptic proteins. Visualization by confocal microscopy followed by
counting of positive puncta per eGFP+ cell revealed a significant GA
repeat length-dependent reduction in SV2 levels in both cortical and
motor neurons (****P < 0.0001; Fig 6A–D). Total neurite length
was unaffected by expression of GA at any repeat length, ensuring
that this was a reduction of synaptic protein content per neurite
length rather than a reduction in overall neurite area (Fig 6C and D;
right panels). Synaptophysin and PSD-95 levels were unchanged
when compared with eGFP alone or across the GA length curve
(Fig EV3B and C). Overall, among the synaptic proteins examined, a
specific, and significant length-dependent reduction of SV2 was
observed both in primary cortical and motor neurons. We have
begun to address potential mechanistic links between GA expression
and SV2 altered levels and localization, by assessing GA colocalization with SV2 protein and mRNA. In cortical neurons transfected
with our mCherry-GA50 construct and stained as mentioned above
at 2 days of expression, we also evaluated GA colocalization with
SV2 protein within SMI-32 neuritic regions (Fig EV4A). Quantification across the GA length curve revealed that with all GA
lengths, a small percentage of SV2 protein has been sequestered into
GA aggregates, approximately 3.5% of total cellular SV2. In order to
assess possible interactions of GA with SV2 mRNA, a custom
beacon probe was generated against SV2 mRNA (Bio-Synthesis,
Inc.). This beacon was co-transfected along with our eGFP-GA50
construct, and cells were evaluated for colocalization following
2 days of GA expression (Fig EV4B). We found that
20.97%  2.67% of the RNA beacon in GA-expressing cells was
colocalized with GA. These intriguing findings will help guide extensive in-depth evaluations of GA interactions in future studies.
SV2 is reduced in C9orf72-ALS patient-derived iPS neurons
We next wished to validate that our findings will be physiologically
relevant to C9orf72-ALS patients. We obtained i3 iPS lines of a
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C9orf72-ALS patient, and the paired isogenic line which had the
GGGGCC repeat expansion removed (Fernandopulle et al, 2018).
These cells were expanded and differentiated into cortical neurons
according to their previously defined protocol and allowed to
mature for 21 days in vitro. At this time, cells were analyzed via
immunofluorescence, qPCR, and immunoblotting. Cortical i3
neurons on coverslips were probed for either SV2 or synaptophysin
and counterstained with neurofilament. Visualization by confocal
microscopy was followed by quantification of the synaptic protein
colocalized with neurofilament. This analysis revealed that SV2 was
again specifically reduced in neurons harboring a C9orf72 repeat
expansion compared with an isogenic control (*P < 0.05; Fig 7A
and C), while synaptophysin levels remained unaltered (Fig 7B and
D). We also tested the overall mRNA levels of SV2 at this time point
in the two i3 lines. In the C9 line, SV2 mRNA was reduced to 0.249fold compared with the paired isogenic line (**P < 0.01; Fig 7E).
We also assessed SV2 at the protein level by preparing cellular
lysates and immunoblotting these samples with a probe for SV2.
Following densitometric analysis compared with total protein loading, we found that SV2 protein was reduced to 0.578-fold compared
with the isogenic line (*P < 0.05; Fig 7F). To assess whether these
findings would also be applicable to iPS-derived motor neurons, cell
pellets were procured from 32-day differentiated control and
C9orf72-ALS iMNs via the Answer ALS Consortium. Immunoblotting of samples derived from these whole-cell lysates with probes
for SV2 and synaptophysin revealed a trend toward reduction in
SV2 levels (P = 0.1116) (Fig 7G and H). Notably, this analysis was
done with genetically unrelated C9orf72-ALS and control lines,
using a protocol that produces a mixed neuronal population with
20–30% Islet1+ motor neurons. It is likely that if the efficiency of
differentiation could be enhanced the reduction of SV2 would be
even more pronounced. Overall, these findings from patient-derived
iPSC lines have supported our SV2 finding in the context of the total
cellular consequences resulting from the C9orf72 repeat expansion.
Replenish SV2 restores synaptic function and attenuates
cellular toxicity
We next sought to establish whether the reduction in SV2 levels in
GA-expressing cells was a viable molecular candidate for therapeutic intervention, through restoration of SV2 levels via transduction
of cortical and motor neurons with lentivirus. We obtained the
rSV2a-eGFP-pRRL plasmid construct, which has previously been
shown to robustly express rat SV2a in vitro (Yao et al, 2010).
Following generation of SV2 lentivirus from this construct, we
infected mature cortical neurons and evaluated them following
4 days of expression for SV2 upregulation at the mRNA and protein
levels by qPCR and immunoblotting, respectively. Compared with
non-transduced control cells, we observed a significant 1.99-fold
increase of SV2 mRNA (**P < 0.01), as well as a significant 1.72fold increase of SV2 protein (***P < 0.001; Fig EV4C and D).
We chose to evaluate any rescue phenotypes using GA50 as our
representative GA length, since it displayed robust cellular effects
in vitro. Initially, we examined whether SV2 puncta levels were
restored in GA50 containing neurons transduced with SV2pRRL
through immunofluorescent staining and analysis following 2 days
of expression. We found that the significant reduction of SV2 puncta
observed in GA-containing cells was normalized to control levels
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Figure 6. Synaptic vesicle component SV2 is reduced in GA aggregate containing neurons.
eGFP-GAn dipeptides were expressed in primary cortical or motor neurons for 48 h, and then immunostained for neurofilament (gray) and SV2 (red).
A, B Representative z-stack confocal images of neurites from eGFP, eGFP-GA50, and eGFP-GA100 expressing cortical (A) or motor (B) neurons. 60× magnification, scale
bar indicates 5 lm.
C, D Quantification of SV2 puncta along neurites in cortical neurons (C) or motor neurons (D) by ImageJ manual counting, normalized to eGFP-only expressing cells. (C)
Cortical neurons demonstrated a significant GA length-dependent reduction, as well as a reduction in all cells containing GA repeats greater than 50 (left panel).
(D) Motor neurons demonstrated a significant GA length-dependent reduction, as well as a reduction in all cells containing GA repeats greater than 100 (left
panel). Evaluation of neurite length by NeuronJ software revealed no differences in total neurite length per cell in cortical neurons (C) or motor neurons (D)
expressing any GA repeat length compared with eGFP alone (right panels).
Data information: Data presented as mean  SEM. One-way ANOVA, post hoc Dunnett’s multiple comparison test, ****P < 0.0001, n = 3 independent biological
replicates, m = 5–7 cells per replicate. Exact P-values can be found in Appendix Table S1.

ª 2020 The Authors

EMBO Molecular Medicine 12: e10722 | 2020

11 of 26

EMBO Molecular Medicine

Brigid K Jensen et al

A

B

C

D

E

F

G

H

Figure 7.

12 of 26

EMBO Molecular Medicine 12: e10722 | 2020

ª 2020 The Authors

Brigid K Jensen et al

◀

EMBO Molecular Medicine

Figure 7. SV2 is reduced in i3 neurons from a C9orf72-ALS patient.
A, B

i3 cortical neurons from a C9orf72-ALS patient and the paired isogenic control were differentiated for 21 days then were immunostained for neurofilament (red),
and SV2 (green) (A) or synaptophysin (green) (B). Shown are representative z-stack confocal images of neurites.
C, D Quantification of SV2 (C) or synaptophysin (D) colocalized with neurofilament normalized to neurofilament area. This analysis revealed a significant reduction in
SV2 levels in the C9orf72 line compared with the isogenic control, while synaptophysin remained unaltered. Data presented as mean  SEM. Unpaired t-test,
*P < 0.05. 15 non-overlapping regions from three differentiated wells for each genotype were evaluated.
E
mRNA was Trizol extracted from three independent wells of C9-ALS and isogenic i3 cortical neurons. RNA was converted to cDNA using the Superscript First-strand
kit, and qPCR was performed using PowerUp SYBR Green. Measurements were normalized to the housekeeping gene GAPDH and then to isogenic levels. Analysis
was performed using the DDCT method. 2DDCT  SE is presented. Unpaired t-test, **P < 0.01.
F
Whole-cell lysates were generated from three independent wells of C9-ALS and isogenic i3 cortical neurons differentiated for 21 days. Lysates were immunoblotted
for SV2 and normalized to total protein loading. Quantification of band intensities revealed a significant decrease in SV2 protein levels in the C9orf72 lines
compared with the isogenic. Data presented as mean  SEM. Unpaired t-test, *P < 0.05.
G, H Whole-cell lysates were generated from iMNs differentiated for 32 days. Lysates were immunoblotted for SV2 (G) or synaptophysin (H). Loading controls were
b-actin or total protein loading. Quantification band intensities normalized to loading controls revealed a trend toward reduction in SV2 protein levels in the
C9orf72 cell lines compared with controls, while synaptophysin levels remained unaltered. Data presented as mean  SEM. Unpaired t-test. Samples from five
independent control and four independent C9orf72 patient lines were used. Exact P-values can be found in Appendix Table S1.
Source data are available online for this figure.

through this exogenous SV2 expression (Fig EV4E and F). While
SV2 levels in GA50 containing cells were still significantly lower than
control cells transduced with SV2pRRL (****P < 0.0001), levels that
were comparable to normal control neurons suggested the potential
for recovery of synaptic function. Using the same array of live-cell
imaging techniques through which we initially detailed disruption
of synaptic release, altered Ca2+ influx, and neuronal toxicity, we
next determined whether restoration of SV2 levels would be capable
of rescuing these cellular defects. First, mature cortical neurons
were transfected with eGFP or eGFP-GA50 and co-transduced with
SV2pRRL lentivirus. Following 2 days of expression, synaptic release
was again measured using our FM4-64 dye paradigm. When
neurons co-expressed GA50 + SV2pRRL, the abrogation of synaptic
release in cells expressing GA50 alone was restored to comparable
levels of that of control GFP neurons (***P < 0.001; Fig 8A).
Calcium influx was also evaluated at 2 days following co-transfection of mCherry-GA50 and gCAMP plus transduction with SV2pRRL.
Similar to the synaptic release results, when neurons co-expressed
GA50 + SV2pRRL, the elevation of Ca2+ influx caused expression of

GA50 alone was restored to comparable levels of that of control
neurons (***P < 0.001; Fig 8B). Finally, cellular toxicity was longitudinally evaluated in both cortical and motor neurons to determine
if restoration of SV2 levels would impact the cellular toxicity caused
by GA. Following the same principle as our Fig 3 longitudinal
survival assay, mature cortical and motor neurons were co-transfected with mCherry or mCherry-GAn and assessed for survival over
time in the presence or absence of SV2 restoration via SV2pRRL
lentiviral transduction. In cortical neurons, the significant cellular
toxicity of GA50 was rescued by restored levels of SV2 via expression of SV2pRRL, with the hazard ratio dropping from 1.473 for GA50
to 0.7277 for SV2pRRL co-expression (****P < 0.0001) (Fig 8C). As a
control, the toxic C9orf72 dipeptide PR50 was also expressed in
neurons with or without SV2pRRL co-expression to determine if this
was a specific GA-mediated result. Assessment of survival of PR50
containing neurons revealed that significant reduction in survival
was observed with or without SV2pRRL, with hazard ratios of
1.772 for PR50 and 1.784 for PR50 + SV2pRRL, respectively
(****P < 0.0001) (Fig 8D). Finally, we also evaluated motor neuron

Figure 8. GA-induced synaptic dysfunction and cellular toxicity can be rescued by replenishment of SV2.
A

Cortical neurons were loaded with FM4-64 dye 48 h after transfection with eGFP-GA50 and transduction with rSV2a-eGFP-pRRL lentivirus. Basal fluorescence was
monitored prior to induced depolarization via perfusion with ACSF containing 50 mM KCl. Graphical representation is the change in fluorescence (DF) normalized
to basal fluorescence (F), DF/F. The final 60 s of baseline recording and 60 s of the depolarization phase are shown; arrow indicates start of depolarization. The lack
of synaptic release in the case of GA50 expression (red line) was rescued back to levels comparable to eGFP controls (pink line) in the case of co-expression of rSV2aeGFP-pRRL (orange line). Statistical significance was determined using the Sidak–Bonferroni method, ***P < 0.001, n = 10 puncta regions from each of 4 biological
replicates.
B
Cortical neurons were co-transfected with mCherry or mCherry-GA50 and GCaMP6f, then transduced with rSV2a-eGFP-pRRL. Green fluorescence intensity was
recorded from identified mCherry-positive neurons. Basal fluorescence was monitored prior to induced depolarization via perfusion with ACSF containing 50 mM
KCl. Quantification of the peak change in fluorescence (DF) following ACSF perfusion normalized to basal fluorescence (F), DF/F. The significant increase in Ca2+
influx observed following GA50 expression (*P < 0.05) is resolved when rSV2a-eGFP-pRRL is co-expressed. Data presented as mean  SEM. One-way ANOVA with
Sidak’s multiple comparisons test, at least 10 cells per condition, pooled from n = 3 independent biological experiments. No significant differences were observed
between mCherry or mCherry + SV2 conditions; groups were merged for this analysis.
C–E Neurons were co-transfected with mCherry-GAn plasmids or mCherry alone and transduced with rSV2a-eGFP-pRRL and then imaged at 24-hour intervals. (C)
Kaplan–Meier survival analysis of cortical neurons expressing GA50 or GA50 + SV2 followed for 13 days. The significant cellular toxicity induced by GA50 is rescued
by SV2 replenishment. While the hazard ratio of GA50 was 1.473, this was decreased to 0.7227 for GA50 + SV2. At least 190 cells per condition were evaluated from a
pooling of n = 3 independent experiments, log-rank Mantel–Cox test, ****P < 0.0001. No significant differences were observed between eGFP or eGFP + SV2
conditions, and groups were merged for this analysis as control. (D) A Kaplan–Meier survival analysis was performed for PR50 and PR50 +SV2 containing cells. Under
these conditions, significant toxicity is observed regardless of increased SV2 levels, with the hazard ratio of PR50 containing cells (1.772) remaining high for those
expressing PR50 + SV2 (1.784). At least 150 cells per condition were evaluated from a pooling of n = 3 independent experiments, log-rank Mantel–Cox test,
****P < 0.0001. No significant differences were observed between eGFP or eGFP + SV2 conditions, and groups were merged for this analysis as control. (E) Kaplan–
Meier survival analysis of motor neurons expressing GA50 or GA50 + SV2 followed for 10 days. The significant cellular toxicity induced by GA50 is rescued by SV2
replenishment. While the hazard ratio of GA50 was 1.345, this was decreased to 0.7769 for GA50 + SV2. At least 200 cells per condition were evaluated from a
pooling of n = 3 independent experiments, log-rank Mantel–Cox test, ****P < 0.0001. All exact P-values can be found in Appendix Table S1.
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longitudinal survival in cells expressing GA constructs as well as the
SV2pRRL rescue construct. The significant toxicity of GA50 (hazard
ratio of 1.345) was once again rescued by SV2pRRL co-expression
(hazard ratio 0.7769) (****P < 0.0001) (Fig 8E). Overall these findings suggest that despite a reduction of SV2 in the presence of GA
dipeptides, intervening in such a way so as to restore normal SV2
levels is sufficient to recover synaptic transmission and synaptic
signaling events as well as to prevent cell death.
Transgenic GA149-CFP mice display a specific reduction in
synaptic component SV2
After investigating the repercussions of GA expression on neuronal
function in vitro, we turned to our animal model to determine
whether similar synaptic consequences also occur in vivo. As we
have previously described, our transgenic mice express a 149-repeat
GA dipeptide, coupled to a cyan fluorescent protein tag (GA149-CFP)
exclusively in neurons of the spinal cord, brainstem, and deep cerebellar nuclei (Schludi et al, 2017). Age-dependent accumulation of
GA inclusions in these regions results in progressive impairments in
gait and balance, without reduction in motor neuron number,
suggesting impaired neuromuscular transmission.
To determine the effects of neuronal GA expression on synaptic
components, levels of SV2, synaptophysin, and PSD-95 were
assessed by immunoblotting samples derived from spinal cords of
these animals. In whole-cell lysates generated from 20-month-old
mice, analysis revealed a significant reduction of SV2 protein in
transgenic animals compared with wild-type controls (*P < 0.05;
Fig 9A), whereas synaptophysin and PSD-95 levels were not significantly altered (Fig 9B and C). Immunohistochemical staining from
cervical sections of paraffin-embedded spinal cords from paired
20-month-old wild-type and transgenic animals revealed no differences in motor neuron number by ChAT staining or by neuronal
DAPI morphology analysis (data presented as mean  SEM.
Unpaired t-test. n = 4 animals per group; Table 1). Additionally,
immunohistochemical staining was performed on sections derived
from snap-frozen hindlimbs within the cohort of 20-month-old mice.
A dramatic reduction of SV2 levels in proximity to neuromuscular
junctions was observed in transgenic GA149 animals compared to
wild type (Fig 10A). Assessment of synaptic proteins SV2 and
synaptophysin at the NMJ confirmed a specific reduction of SV2 in
transgenic animals compared with controls (*P < 0.05), while again
synaptophysin levels were unaltered (Fig 10B and C). Thus, from
tissue derived from GA149 animals, we have confirmed, in vivo, a
specific reduction of SV2 protein prior to cell death of affected spinal
cord motor neurons.

Discussion
Loss of functional communication between presynaptic motor
neurons and postsynaptic muscle is the hallmark feature of all forms
of ALS and has been advocated as a promising target for therapeutic
intervention. In a recent report using a mouse model expressing the
ALS-causative TDP-43Q331K mutation, neurotransmission deficits in
the form of defects in synaptic vesicle fusion and release, decreased
probability of release, and reduced quantal content of vesicles were
described 7 months prior to motor neuron loss (Chand et al, 2018).
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The disease causative GGGGCC hexanucleotide repeat expansion in
C9orf72 is no exception to this principle; in fact, early synaptic deficits have now been identified in paradigms modeling this mutation
and have been suggested as potential targetable disease features
(Sareen et al, 2013; Devlin et al, 2015). Previous reports in two
independent Drosophila melanogaster models have investigated
structural features of the neuromuscular junction in flies expressing
30 or more GGGGCC repeats. These groups contributed valuable
insight into C9orf72-ALS synaptic pathology, as both reported significant reductions in active zone number (Freibaum et al, 2015;
Zhang et al, 2015). Importantly, they also demonstrated significant
decreases in synaptic bouton number (Freibaum et al, 2015) as well
as attenuation of evoked potentials due to reduced synaptic quantal
content (Zhang et al, 2015). As vitally important as these studies
have been for our understanding, the outcomes of expanded
GGGGCC repeat stretches expressed in the fly could be resultant
from either repeat expansion RNA, dipeptide repeat proteins
(DPRs), or a synergistic combination of both. Within this study, we
pinpointed our focus toward DPR-mediated effects.
In agreement with several other groups, our previous findings
demonstrated that glycine-arginine (GR) and proline-arginine (PR)
dipeptides were rapidly and robustly toxic to primary cortical and
motor neurons (Mizielinska et al, 2014; Wen et al, 2014; Boeynaems et al, 2016). In this model, when cortical neurons were
examined to 7 days or motor neurons to 3 days post-expression,
GA up to 400 dipeptide repeats did not yet precipitate neuronal
cell death (Wen et al, 2014). In our transgenic mouse model,
which drives GA149-CFP off of the Thy-1 promoter leading to
expression in spinal cord and brainstem, we have observed
pronounced motor deficits that correlate with increasing burden
of GA inclusions, but with a lack of motor neuron dropout (Schludi et al, 2017). These results were intriguing as work examining
GA effects in maturing neurons demonstrated reduced dendritic
complexity and cell death (May et al, 2014). Additionally, a
second mouse model was published which confines GA50 expression to the cortex. While this model also develops motor and
cognitive behavioral deficits by 6 months of age, concomitant
neuronal loss and brain atrophy also occurred (Liu et al, 2016).
These conflicting findings and the possibility that motor deficits
and neuronal dysfunction may precede neuronal cell death led us
to thoroughly investigate the nuances of GA expression in mature
neurons in vitro and ultimately led to our examination of synaptic
transmission and synaptic proteins.
We discovered that in addition to cytosolic inclusions, GA aggregates were also present within neuritic regions and were not
stationary but rather displayed different degrees of mobility in a
repeat length-dependent fashion. In response to a stimulus to evoke
synaptic transmission, functional analysis revealed that synaptic
unloading was significantly attenuated in GA-expressing neurons.
By investigating mechanisms by which this may occur, we uncovered that both cortical and motor neurons containing GA aggregates
demonstrated significant increases in Ca2+ influx compared to
control neurons upon depolarizing conditions. Probing the levels of
synaptic proteins revealed that synaptic vesicle-associated protein
2, SV2, was specifically reduced. This specific reduction in SV2 was
confirmed in i3 differentiated neurons carrying a C9orf72 GGGGCC
repeat expansion, suggesting that this finding will be applicable to
patients carrying the full complement of C9orf72 expansion-
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Figure 9. SV2 is specifically reduced in spinal cord lysates of symptomatic transgenic GA149-CFP mice.
Spinal cord lysates were generated from fresh-frozen tissue of 20-month-old mice either expressing GA149-CFP under the Thy1 promoter (Tgx GA149) or wild-type controls.
A–C Lysates were immunoblotted for SV2 (A), synaptophysin (B), and PSD-95 (C). Total protein levels were determined by imaging the Mini-PROTEAN TGX stain-free gel
prior to transfer. Quantification of band intensities normalized to total protein loading revealed a significant reduction in SV2 protein levels in the GA-expressing
cohort compared with wild-type animals, while synaptophysin and PSD-95 levels remained unaltered. Data presented as mean  SEM. Unpaired t-test, *P < 0.05.
A total of four animals per group were examined. Exact P-value can be found in Appendix Table S1.
Source data are available online for this figure.

16 of 26

EMBO Molecular Medicine 12: e10722 | 2020

ª 2020 The Authors

Brigid K Jensen et al

EMBO Molecular Medicine

Table 1. Motor neuron counts by immunocytochemical staining.
ChAT+

DAPI+

Wild type

14.50  1.50

16.50  2.53

GA149-CFP

14.25  1.37

15.38  1.00

mediated cellular toxicities. While we found that cortical and motor
neurons do eventually succumb to GA-induced cell death (at time
points extended past our originally published assessment (Wen
et al, 2014)), the synaptic changes we have described occur several
days prior to cellular demise. Notably, when we employed a strategy for restoration of SV2 levels in GA-expressing cells, we were
able to functionally restore synaptic release, prevent aberrant Ca2+
signaling, and rescue GA-induced cellular toxicity. Finally, we
returned to our in vivo model, wherein we validated our observation of a specific reduction in SV2 levels. Despite being aged to 20
months, we still did not observe a reduction in spinal cord motor
neuron number in transgenic GA149-CFP mice compared with agematched controls.
In our models, SV2 levels are diminished in vitro and in vivo.
SV2, also known as synaptic vesicle glycoprotein 2, is an essential component found in all synaptic vesicles (Feany et al, 1992).
In addition to a proposed role in the transport of neurotransmitters into synaptic vesicles (Feany et al, 1992), SV2 has been
linked to several mediators of Ca2+ signaling which regulate and
facilitate synaptic vesicle fusion events. SV2 is required for
appropriate endocytic sorting of the Ca2+ sensor synaptotagmin
1 to synaptic vesicles (Kaempf et al, 2015), as well as appropriate voltage-dependent Ca+2 channel function at synapses (Vogl
et al, 2015). A complicated story arises when SV2 levels are
reduced, as different strategies have reported varying implications
for synaptic transmission. In a mouse model of SV2 knockdown,
two research groups have reported that responses to low
frequency stimulation remained normal (Crowder et al, 1999;
Janz et al, 1999). However, upon high-frequency successive stimulation, cultured neurons from these animals displayed sustained
increases in Ca2+-dependent synaptic transmission, which was
suggested to explain an observed epileptic behavioral phenotype
(Janz et al, 1999). In contrast, a third group has reported a
significant reduction in amplitude of single evoked potentials in
cultured hippocampal neurons from these animals (Custer et al,
2006). They also went on to demonstrate a reduction in the
readily releasable pool of synaptic vesicles, as well as a reduced
release probability (Custer et al, 2006). Genetic deletion of SV2
also leads to a reduction in spontaneous inhibitory potentials
generated from GABAergic interneurons (Crowder et al, 1999).
Taken together with our findings, particularly the results demonstrating the restoration of synaptic function and viability of GAexpressing neurons following SV2 replenishment, the loss of SV2
we observe in GA-expressing neurons is a prime candidate for
the prevention of synaptic unloading in our ACSF perfusion stimulation paradigm. In vivo, a gradual reduction of properly
released vesicles from cortical and motor neurons over time
would have a strong impact on responses generated in recipient
postsynaptic cells. Such a reduction in neurotransmitter inputs
may lead to further improper signaling throughout the cortex,
spinal cord, and at neuromuscular junctions. While we do not
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suspect or propose that the loss of SV2 is the root cause of ALS
in these patients, it should be considered as a further contributing factor to the multifactorial abnormal environment created by
the presence of the C9orf72 hexanucleotide repeat expansion,
associated RNA foci, and the other dipeptide repeat protein variants.
Intracellular Ca2+ levels are tightly regulated in all cells and
particularly in neurons (Zundorf & Reiser, 2011). Dysregulation of
internal Ca2+ has dramatic consequences for many fundamental
cellular functions and consequently has been implicated in a variety
of neurodegenerative conditions (Zundorf & Reiser, 2011). For
example, many of the Alzheimer disease linked mutations and the
toxic amyloid-beta fragment itself can each independently elevate
levels of internal Ca2+ (Chakraborty & Stutzmann, 2011). It is now
thought that Ca2+ dysregulation may be one of the early triggering
events in AD pathogenesis which then feeds-forward into pathological signaling cascades (Chakraborty & Stutzmann, 2011). When
looking at Ca2+ influx in response to a stimulus designed to evoke
neuronal firing, we found that cortical and motor neurons containing GA dipeptides displayed a significantly more robust response
when compared with control cells. While we have not yet
pinpointed the mechanism, we have considered several possibilities
leading to this outcome. GA aggregates could be directly impacting
cellular membrane permeability, or indirectly altering permeability
through interactions with Ca2+ channels. An alternative possibility
is that this is a feed-forward mechanism of the cell to address the
loss of synaptic vesicle component proteins. As Ca2+ is required for
effective synaptic vesicle fusion (Schneggenburger & Rosenmund,
2015), if the synaptic vesicles release is impaired, higher Ca2+ influx
could constitute a feed-back compensatory mechanism that neurons
have in place to raise the probability of successful release of those
vesicles. Finally, as was outlined above, perturbation of Ca2+ levels
could be a direct side effect of the altered levels of SV2 resulting
from GA aggregates in neurites. Diminished SV2 interaction with
Ca2+ transport proteins and Ca2+ sensors required for synaptic vesicle fusion could have dramatic implications for Ca2+ entry and
signaling at the synapse. While we have provided evidence that
restoring SV2 levels alleviates increased Ca2+ influx upon neuronal
stimulation, we have not yet isolated the mechanism by which these
fluctuations of SV2 levels contribute to our observations regarding
cellular Ca2+ entry in our model. Restoration of Ca2+ homeostasis
has been proposed as a therapeutic strategy in neurodegeneration,
and our data suggest that patients with C9orf72-ALS/FTD may also
benefit from recovery of cellular Ca2+ regulation. Determining how
and why this is occurring will be a valuable insight into possible
therapeutic interventions for GA-mediated synaptic transmission
deficits.
Concerns have commonly been raised as to the relevance of
DPRs in terms of mechanistic contribution to C9orf72-ALS/FTD,
due to the abundance and widespread DPR distribution throughout brain and spinal cord prior to neuronal cell death (Mackenzie et al, 2013, 2015; Gomez-Deza et al, 2015). Our findings
here suggest that aggregates containing GA can be found within
neuritic regions and affect synaptic transmission and synaptic
vesicle composition. Our data indicate that by 48 hours, neurons
expressing GA peptides display this aberrant elevation of Ca2+
influx, reduction in SV2 levels, and abrogation of synaptic
unloading. In future studies, detailing the sequence in which
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Figure 10. SV2 is specifically reduced at neuromuscular junctions of symptomatic transgenic GA149-CFP mice.
Muscle sections (30 lm) were cut from snap-frozen tissue of 20-month-old GA149 mice (Tgx GA149) or wild-type controls. Immunohistochemical staining was performed to
assess synaptic protein levels in proximity to NMJs. Sections were immunostained for SV2 or synaptophysin and counterstained with neurofilament.
Left Panels: Representative images show SV2 levels (green) in proximity to a-bungarotoxin-positive NMJs (red) in wild-type animals (top) versus GA149 animals
(bottom). Right panels: Representative images show SV2 levels (green) overlapping with neurofilament (blue) at synaptic terminals approaching muscle in wild-type
animals (top) versus GA149 animals (bottom).
B, C Quantification of SV2 (B) or synaptophysin (C) colocalized with neurofilament and normalized to neurofilament area. This analysis revealed a significant reduction
in SV2 levels in GA149 animals compared with wild types, while synaptophysin remained unaltered. Data presented as mean  SEM. Unpaired t-test, *P < 0.05. A
total of 10 non-overlapping regions of muscle from each of five animals per group were evaluated. Exact P-values can be found in Appendix Table S1.
A
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these events occur will identify the mechanism involved and
provide insight for a targeted approach for preventing the resultant downstream synaptic dysfunction. We suspect that disruption of functional synaptic signaling prior to overt loss of motor
neurons is the culprit for the behavioral phenotypes observed in our
GA149 mouse model. In multiple instances from human C9orf72
patient cases, staining of postmortem tissue samples has revealed
neurons containing GA dipeptide aggregates with dystrophic neurites
(Vatsavayai et al, 2016; Sakae et al, 2018). A recent article further
solidifies the potential pathogenic nature of GA and therapeutic
value of targeting this dipeptide in C9orf72 ALS/FTD. In this study,
administration of a GA targeting antibody in a mouse model of
C9orf72-ALS/FTD, successfully attenuated neurodegeneration,
improved behavioral outcomes, and increased survival (Nguyen
et al, 2020). In human patients, we cannot disentangle the effects of
the various C9orf72 proposed pathogenic mechanisms, but along
with this very recently published work, our in vitro and in vivo studies certainly lend further credibility to the idea that GA may have
synaptic consequences which can be therapeutically targeted.
Overall, we have made some headway in understanding how the
presence of GA DPR aggregates may lead to behavioral motor deficits
preceding death of motor neurons in the spinal cord. Additionally,
these findings help better clarify the previously conflicting reports on
whether GA is toxic to neurons (May et al, 2014; Wen et al, 2014;
Zhang et al, 2014). We propose that progressively aberrant synaptic
transmission over time as a result of GA neuritic inclusions leads to a
very gradual toxicity of neurons. This concept would also begin to
explain how there is such widespread distribution of DPRs and
particularly of GA in brain and spinal cord of patients of C9orf72ALS/FTD without a correlation to disease severity or to regions
where neuronal dropout is most severely affected (Mackenzie et al,
2013; Davidson et al, 2014, 2016; Gendron et al, 2015; Gomez-Deza
et al, 2015; Schludi et al, 2015). It has also recently been established
that DPRs including GA can be transmitted from cell to cell (Chang
et al, 2016; Westergard et al, 2016). Here, we have shown that GA
inclusions are present and mobile within neurites at time points
greatly preceding cell death, which would allow ample time for cellto-cell transmission events to take place. In vivo, a consequence of
such long-term cell-to-cell spread would be a pervasive area of
affected tissue, which will slowly diminish in synaptic transmission
capacity over time.

Materials and Methods
Reagents
Antibodies
Abcam: anti-MAP2 (Abcam Cat# ab5392, RRID:AB_2138153), antiNeurofilament Heavy (Abcam Cat# ab8135, RRID:AB_306298), antiPSD-95 (Abcam Cat# ab18258, RRID:AB_444362), anti-SV2 (Abcam
Cat# ab32942, RRID:AB_778192); Covance: anti-SMI32 (Covance
Research Products Inc Cat# SMI-32R-100, RRID:AB_509997); DSHB:
anti-SV2 (DSHB Cat# SV2, RRID:AB_2315387); GeneTex: anti-p62/
SQSTM-1 (GeneTex Cat# GTX100685, RRID:AB_2038029); Millipore:
anti-ChAT (Millipore Cat# AB144P, RRID:AB_2079751); Thermofisher: anti-Synaptophysin (Thermo Fisher Scientific Cat# MA516402, RRID:AB_2537921).
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Constructs
eGFP-GAn constructs used were previously characterized in Ref.
Wen et al (2014). mCherry-GAn constructs were subcloned from
these vectors. pGP-CMV-GCaMP6f was a gift from Dr. Douglas Kim
(Addgene plasmid #40755; Chen et al, 2013). rSV2a-eGFP-pRRL was
a generous gift from Dr. Sandra Bajjalieh.
Other reagents
Agilent: Dako target antigen retrieval solution; AmericanBio: non-fat
dry milk omniblock; Bio-Rad Laboratories: 4–20% Mini-PROTEAN
TGX stain-free gels, broad-spectrum molecular weight ladder, Tris/
glycine running buffer, Tris/glycine transfer buffer; Decon Laboratories Inc: ethanol; Electron Microscopy Sciences: 16% paraformaldehyde, Citifluor AF3; LI-COR Biosciences: IRDye 680 RD donkey antirabbit IgG, IRDye 680RD goat anti-mouse IgG, IRDye 800CW donkey
anti-mouse IgG, IRDye 800CW goat anti-rabbit IgG; Millipore Sigma:
b-mercaptoethanol, bovine serum albumin (BSA), Bradford reagent,
calcium chloride dihydrate, deoxycholic acid, dithiothreitol (DTT),
(ethylenedinitrilo)tetraacetic acid (EDTA), D-glucose, HEPES, hydrogen peroxide, immobilon-FL membranes, poly-D-lysine, magnesium
chloride hexahydrate, OptiPrep density gradient medium, sodium
dodecyl sulfate, sodium phosphate; National Diagnostics: Histoclear;
Takara Bio USA: Lenti-X Packaging Single Shots, Lenti-X Concentrator, Lenti-X Gostix; Thermofisher: AlexaFluor546-conjugated antimouse or anti-rabbit secondary antibodies, AlexaFluor647-conjugated anti-mouse or anti-rabbit secondary antibodies, a-bungarotoxin AlexaFluor594 conjugate, B27 supplement, diamidino-2phenylindole (DAPI), FM4-64 fluorescent dye, glutamine, heat-inactivated horse serum, Hoechst 33258 pentahydrate (bis-benzimide),
laminin, Lipofectamine 2000 reagent, LysoTracker Deep Red,
methanol, MitoTracker Deep Red FM dye, neurobasal medium,
neutravidin protein, normal goat serum, phosphate-buffered saline
(PBS), potassium chloride, protease inhibitors, sodium bicarbonate,
sodium chloride, SYTO RNASelect Green Fluorescent cell stain, Tris–
HCl, Triton X-100, trypsin, Tween-20; US Biological: Nonidet (NP40); Vector Labs: Vectashield Antifade mounting media with DAPI.
Primary rat cortical and motor neuron cultures
All experiments were performed in accordance with the guidelines
set forth by the Institutional Animal Care and Use Committees at
Thomas Jefferson University. Primary rat cortical neurons were
isolated from embryonic day 18 rats as previously described (Kayser
et al, 2006; Hanamura et al, 2017). Timed-pregnant female Sprague
Dawley rats were procured from Charles River and delivered on the
day of embryonic dissection. Immediate transfer to the laboratory
occurred upon arrival. Dissociated cortical neural cell suspensions
were plated on poly-D-lysine-coated coverslips or 35-mm dishes
with glass-bottom centers in Neurobasal medium with B27 supplement at 37°C with 5% CO2. Primary rat motor neurons were
prepared from embryonic day 14.5 spinal cords with slight modifications to the established protocol (Magrane et al, 2012). The
following morning, embryonic spinal cords were dissected and
mechanically fragmented into small pieces, then incubated with
0.025% trypsin. Following manual trituration, cells were passed
through a 4% (w/v) bovine serum albumin (BSA) cushion and then
centrifuged through 10.4% (v/v) Optiprep cushion (Sigma) for
55 min without brake. Collected motor neuron bands were then
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spun through 2 sequential 4% (w/v) BSA cushions. Cells were
resuspended in Neurobasal medium with B27 supplement, glutamine (0.25%), b-mercaptoethanol (0.1%), and horse serum (2%).
Dissociated motor neurons were plated on poly-D-lysine and
laminin-coated coverslips or 35-mm dishes with glass-bottom
centers and maintained at 37°C with 5% CO2. Animals were housed
in the Bluemle Life Sciences Animal Facility following our IACUCapproved protocol in standard cages with ad libitum access to food
and water.
Neuronal transfections
Transfection of primary cortical and motor neurons with plasmids
encoding GA at different lengths or control eGFP-FLAG were
performed as previously reported (Wen et al, 2014). For GCaMP
experiments requiring use of the 488 FITC channel to assess Ca2+
levels, the eGFP tag was switched for mCherry using standard
subcloning techniques. In order to represent functionally mature
neurons, we began all experiments at time points where primary
neuron cultures were capable of excitatory synaptic communication.
By DIV7, cortical neuron cultures derived from rat express a full
complement of NMDA and AMPA receptor subunits (Janssens &
Lesage, 2001), and by DIV9, the time point we have examined for
neuronal function is functionally competent for synaptic transmission (Virdee et al, 2017). Similarly, primary rat motor neurons have
been shown to undergo robust glutamate-induced excitotoxicity at
DIV7, underlying our rationale for beginning motor neuron experiments at DIV5 and assessment at DIV7 (Vincent et al, 2004). Transfection of DIV7 cortical neurons and DIV5 motor neurons was
accomplished through the use of Lipofectamine 2000 reagent and
1 lg total DNA/well. When co-transfection was necessary, TdTomato or GCaMP6f was introduced at a 1:4 cDNA ratio with the
desired eGFP or mCherry GA constructs, respectively.
i3 cortical neuron cultures
Cortical neurons derived from iPSCs were produced using transcription factor-mediated differentiation using a technique dubbed i3
neurons (integrated, inducible, and isogenic). Two cell lines were
utilized, which were derived from a patient with a C9orf72 repeat
expansion, and an isogenic control in which the repeats were
removed from the patient line. These were kind gifts from Dr.
Michael E. Ward and Dr. Kevin Talbot. Prior to tissue donation and
generation of pluripotent stem cells, informed consent was obtained
from the C9orf72 ALS patient. The tissue collection conformed to the
principles set out in the WMA Declaration of Helsinki and the
Department of Health and Human Services Belmont Report. In the
iPS stage, cells were maintained in Essential 8 Flex media (Gibco) on
matrigel-coated plates (Corning). Differentiation was performed
using the techniques outlined in Fernandopulle et al (2018) in which
the master neuronal transcriptional regulator neurogenin-2 (NGN2)
was stably integrated into a safe harbor locus in the iPS lines under
the control of a doxycycline-inducible promoter. To differentiate iPS
cells into cortical neurons, cells were dissociated into single cells and
plated on matrigel-coated plates in induction media (DMEM/F12,
N2, NEAA, and L-glutamine) containing 2 mg/ml doxycycline. Cells
were treated with doxycycline for 3 days before being dissociated
and plated on PLO-coated plates. Cells were then allowed to mature
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for an additional 18 days in cortical maturation media consisting of
BrainPhys media (STEMCELL) supplemented with BDNF, NT-3, and
Laminin, with half media changes twice weekly. Cells were either
harvested or fixed 21 days post-differentiation.
iMN lysates
iMNs cell pellets were a generous gift from the Answer ALS Consortium. iMNs were generated from control and C9orf72-ALS patients
and were grown and differentiated according to the protocol set
forth by Neurolincs (http://neurolincs.org/technologies/). Prior to
tissue donation and generation of pluripotent stem cells, informed
consent was obtained from all consortium participants. Tissue
collection protocols conformed to the principles set out in the WMA
Declaration of Helsinki and the Department of Health and Human
Services Belmont Report. The spinal neuron protocol used reproducibly generates a mixed neuronal population including 20–30%
Islet1-positive neurons. Following 32 days of differentiation, iMNs
were rinsed with PBS, scraped with a cell scraper, and pelleted by
centrifugation at 1,000 g for 5 min. The supernatant was aspirated;
pellets were flash-frozen in liquid nitrogen and were stored at
80°C. In our hands, these cells were resuspended in RIPA buffer,
and immunoblotting was performed as described.
Immunocytochemistry
Primary neuron cultures on glass coverslips were fixed in 4%
paraformaldehyde for 8 min. Cells were permeabilized and blocked
in phosphate-buffered saline (PBS) with 5% BSA and 0.1% Triton
X-100 for 1 h at room temperature, incubated with primary antibodies at 4°C overnight, and secondary antibodies at room temperature
for 1 h. Coverslips were affixed to slides in Vectashield Antifade
mounting media with DAPI (Vector Labs) to stain nuclei. Three PBS
washes occurred between each step. The following primary antibodies were used: anti-SMI32 (Covance Research Products Inc Cat#
SMI-32R-100, RRID:AB_509997, 1:1,000), anti-MAP2 (Abcam Cat#
ab5392, RRID:AB_2138153, 1:5,000), anti-Neurofilament Heavy
(Abcam Cat# ab8135, RRID:AB_306298, 1:1,000), anti-SV2 (DSHB
Cat# SV2, RRID:AB_2315387, 1:200), anti-Synaptophysin (Invitrogen SP11, Thermo Fisher Scientific Cat# MA5-16402, RRID:
AB_2537921, 1:200), anti-PSD-95 (Abcam Cat# ab18258, RRID:
AB_444362, 1:1,000), and anti-p62/SQSTM-1 (GeneTex Cat#
GTX100685, RRID:AB_2038029, 1:1,000). Secondary antibodies
used at a 1:500 dilution were AlexaFluor546 or AlexaFluor647conjugated. Confocal microscopy was used to capture images
(Olympus FV1000). For each field of view, 10 images were acquired
with a 1lm step size, which were projected into a single z-stack
image. Ten non-overlapping fields per coverslip were generated for
experiments requiring quantitative analysis. For all microscopybased imaging, laser and filter settings for each experiment were
calibrated according to internal experimental control groups (i.e.,
eGFP or mCherry-expressing cells), to account for biological variability and ensure reproducibility.
Assessment of synaptic protein puncta and neurite length
GAn was transfected into neurons. At 48 h post-transfection, neurons
were immunostained for synaptic component proteins SV2,
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synaptophysin, or PSD-95, counterstained with neurofilament and
DAPI, and imaged by confocal microscopy. Quantification of puncta
for each of the aforementioned synaptic components along neurites
in eGFP+ cells was accomplished using NIH ImageJ software
(V1.50i, Bethesda, MD). Puncta were assigned on the z-stack projection images based visually on localization within the neurofilament
area and distinct borders separating them from adjacent puncta. To
determine total neurite length, images were analyzed using the
NeuronJ plug-in feature of ImageJ. In eGFP+ cells, each neurite was
individually traced, with the sum total of length per cell used for
analysis.
Live-cell aggregate, mitochondrial, lysosome, and total
RNA trafficking
Neurons underwent live-cell imaging 48 h after GAn expression. A
high-resolution confocal microscope was used to rapidly capture
images to assess individual GA aggregate, mitochondria, lysosome,
and RNA velocities. GAn aggregates were observed through the use
of the 488 nm laser. MitoTracker Deep Red FM dye (Molecular
Probes, 50 nM) labeled mitochondria. This cell-permeable
compound has an excitation maximum at 644 nm, enabling visualization with a 637 nm laser. Brightfield images were taken to define
neurite tracts. Images were taken at 2-s intervals for 5 min. LysoTracker Deep Red (Molecular Probes, 50 nM) and SYTO RNASelect
Green Fluorescent cell Stain (Molecular Probes, 500 nM) instead
label lysosomes and total RNA respectively but operate under the
same principles as MitoTracker, using the same imaging parameters.
LysoTracker has an excitation maximum of 647 nm, still allowing
visualization with the 637 laser, while SYTO RNASelect has a peak
excitation at 490 nm, switching usage to the 488 laser, and requiring
our transfections to be performed with our mCherry-based GA
constructs. Individual velocities for GAn aggregates, mitochondria,
lysosomes, and total RNA were determined using ImageJ software
through features of the kymograph analysis function.
SV2 mRNA Beacon
A target probe specific for SV2 mRNA was obtained through
Bio-Synthesis, Inc. with the sequence 50 [Cy5]GAACCAGGTGGTGA
CTGTTTA[BHQ-2]30 . This was resuspended at 100 lM in TE buffer
(pH 8.0) and aliquoted for use. The day prior to transfection,
2.7 ll of neutravidin solution was added to a 9 ll volume of
beacon and incubated for 1.5 h at room temperature shielded from
light and then moved to 4°C overnight. This solution was then
added along with the normal transfection components for eGFP or
eGFP-GA50 along with a co-transfected td-Tomato cell-filling plasmid. Following 2 days of expression, confocal imaging was used to
assess beacon and GA cellular localization.
Synaptic vesicle release
Vesicle exocytosis was measured through application of FM4-64
fluorescent dye (Invitrogen), using TRITC imaging parameters
(Gaffield & Betz, 2006; Verstreken et al, 2008). After 48 h of
eGFP-GAn expression, neurons were incubated with 10 lM FM464 dye in high K+ ACSF, followed by a wash in low-K+ ACSF to
regain baseline. High K+ ACSF (ACSF Stim: 95 mM NaCl, 50 mM
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KCl, 5 mM sodium bicarbonate, 1.2 mM sodium phosphate,
1 mM MgCl2 hexahydrate, 10 mM glucose, 10 mM HEPES, and
1.33 mM CaCl2 dihydrate) promotes neuronal firing and uptake of
dye through vesicle recycling. Low-K+ ACSF (140 mM NaCl,
5 mM KCl, 5 mM sodium bicarbonate, 1.2 mM sodium phosphate, 1 mM MgCl2 hexahydrate, 10 mM glucose, and 10 mM
HEPES) allows for cell recovery and normalization to baseline.
Using our Nikon Eclipse Ti microscope, eGFP+ cells were identified, and then, baseline measurements were acquired at 40×
magnification on the TRITC channel for 3 min, with images
captured every second. Cells were stimulated by perfusion with
ACSF Stim, with images captured every second for 2 min. Signal
normalization to average baseline recording accounted for any
initial variability in dye loading. Ten FM4-64 puncta regions were
selected from each eGFP+ neuron for analysis using NIS-Elements
Imaging software. Kinetics are presented as change in fluorescence (DF) normalized to basal fluorescence (F), DF/F, as an
indicator of stimulated dye release.
Neuronal Ca2+ imaging
Neurons were co-transfected with mCherry-GAn constructs and
pGP-CMV-GCaMP6f (a gift from Douglas Kim; Addgene plasmid
#40755; Chen et al, 2013). After 48 h, mCherry+ cells were identified and cells were switched to a low potassium artificial cerebrospinal fluid (ACSF Low-K+) without pH indicator dyes for liveimaging purposes. Basal GCaMP fluorescence intensity (FITC channel) was monitored for 3 min prior to induced depolarization of
neurons with ACSF Stim with or without CaCl2. The contribution of
Ca2+ influx was determined by stimulation in ACSF containing high
KCl but no Ca2+. Images were captured at 40× magnification at
250 ms intervals. Imaging proceeded for an additional 3 min postinitiation of ACSF perfusion. Using NIS-Elements Imaging software,
ROIs of the cell soma were produced and fluorescence values generated across the imaging session. Following baseline normalization,
the peak change in fluorescence DF/F value was recorded for each
mCherry+ neuronal cell body.
Longitudinal live-cell imaging survival analysis
Cortical and motor neurons co-transfected with eGFP-GAn and
td-Tomato plasmids underwent longitudinal live-cell imaging as
previously described to perform survival and risk of death analyses for poly-GA tracts spanning up to 400 repeats (Wen et al,
2014). With our fully automated microscopy system utilizing a
Nikon Eclipse Ti microscope and CoolSNAP ES2 high-performance CCD camera, stage and shutter movements, focusing, and
image acquisition are all controlled by NIS-Elements Imaging
software (Nikon). This system allows for hundreds of neurons
from each group to be imaged at 24-h intervals. Td-tomato fluorescence was used as a marker of cell survival, as loss of fluorescence stemming from plasma membrane disruption indicates
cell death. eGFP and Td-tomato signals were monitored for
13 days in cortical neurons and 10 days in motor neurons.
Visual inspection of files generated from the automated imaging
protocol enabled assessment of survival for individual neurons
over time, with death defined as the day on which a neuron lost
td-Tomato fluorescence.
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Quantitative reverse transcription–polymerase chain
reaction (qRT–PCR)
The expression of SV2 in i3 cortical neuron cultures 21 days postdifferentiation and cortical neurons following 4 days of SV2 upregulation via rSV2a-eGFP-pRRL lentiviral expression was quantified
using quantitative reverse transcription–polymerase chain reaction
(qRT–PCR). mRNA was extracted with Trizol, and 500 ng of RNA
was converted to cDNA by the Invitrogen Superscript First-strand
kit. Quantitative PCR was performed using PowerUp SYBR Green.
Samples were measured in triplicate for each experiment from three
independently differentiated wells of each genotype for the i3
cultures, and three independently treated wells for the cortical
neuron groups. Data were normalized using GAPDH levels and
analyzed according to the DDCT method. Primer pairs obtained from
Integrated DNA Technologies (Coralville, IA) for each gene are
listed. Primers for i3 human: SV2 forward: CTG CTC CCA GTG ATG
GTT ATT, SV2 reverse: GAT CTC ATC ATC CTC GTC ATG G.
Primers for rat cortical neurons: SV2 forward: GAA CCA GGT GGT
GAC TGT TTA, SV2 reverse: TCC AGC AAC GGA ATG ATG AG.
Primers for GAPDH can be used cross-species and were used for both
experiment groups. GAPDH forward: AGG TCG GTG TGA ACG GAT
TTG, GAPDH reverse: TGT AGA CCA TGT AGT TGA GGT CA.
Production of rSV2a-eGFP-pRRL lentivirus
We obtained the rSV2a-eGFP-pRRL lentiviral construct as a generous
gift from the Bajjalieh laboratory at the University of Washington,
which produces rat SV2 coupled with an eGFP tag (Schivell et al,
1996, Yao et al, 2010). Using the manufacturer’s protocol, we generated lentiviral particles in-house by Lenti-X Packaging Single Shots
and concentration with Lenti-X Concentrator (Takara Bio). Lentiviral
GoStix determined effective viral production. 1 ll of virus was added
per 500 ll of cell culture medium. Following 4 days of expression in
mature cortical neurons, effective SV2 upregulation of lentiviraltransduced neurons compared to untreated neurons was determined
following qPCR and immunoblot analysis. This effective virus was
then used at the designated volume-based ratio for all rescue experiments. Virus was always added immediately following the completion of the transfection protocol to express GA constructs.
Immunoblotting and immunohistochemistry of mouse tissue
All animal experimental protocols were conducted in accordance
with the European and German national guidelines for the use of
animals and were approved by the governmental committee (Regierungspräsidium Oberbayern, Germany).
Immunoblotting
Fresh-frozen spinal cords were prepared from 20-month-old GA149CFP and wild-type mice in the C57BL/6N background, which have
been previously validated and characterized (Schludi et al, 2017).
Mice were housed in standard cages, in a pathogen-free facility with
a 12-h night/day light cycle. Animals were given ad libitum access to
food and water. All experiments were performed in accordance with
the guidelines set forth by the Institutional Animal Care and Use
Committees at Thomas Jefferson University. Dissociated single-cell
suspensions were prepared by homogenization in buffer containing:
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10 mM HEPES pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 0.5 mM DTT,
and 1:100 protease inhibitor cocktail, followed by centrifugation at
845 g at 4°C for 5 min. Cells were resuspended in RIPA buffer
(150 mM NaCl, 1% Nonidet (NP-40), 0.5% deoxycholic acid, 0.1%
sodium dodecyl sulfate, 50 mM Tris–HCl, 2 mM EDTA, and 1:100
protease inhibitor cocktail), pulse-sonicated 3 times for 10 s each
with 2 min rest on ice between rounds, and spun at 21,130 g at 4°C
for 30 min. Protein concentrations of supernatant fractions were
determined by the Bradford method. 5 lg of protein was loaded onto
4–20% Mini-PROTEAN TGX stain-free gels for electrophoretic separation, along with a broad-spectrum molecular weight ladder. After
separation, total protein levels were assessed by a Bio-Rad
ChemiDoc Touch Imaging System using the pre-set stain-free gel
parameters. Proteins were transferred onto Immobilon-FL
membranes (Millipore) and blocked in PBS with 0.1% Tween-20
(PBST) and 5% milk for 30 min at room temperature. Membranes
were incubated overnight at 4°C with primary antibodies in
PBST + 5% milk. The following primary antibodies were used: antiSV2 (Abcam ab32942, Abcam Cat# ab32942, RRID:AB_778192,
1:1,000), anti-synaptophysin (Thermo Fisher Scientific Cat# MA516402, RRID:AB_2537921, 1:1,000), and anti-PSD-95 (Abcam Cat#
ab18258, RRID:AB_444362, 1:1,000). Following PBST washes,
membranes were incubated with antigen-specific fluorescent probeconjugated secondary antibodies (1:15,000 dilution LiCor secondaries) in PBST + 5% milk for 1 h at room temperature. Membranes
were visualized using an Odyssey Infrared Imaging System (LiCor)
and ImageStudio software. Using ImageJ, bands of interest were
specified at the heights corresponding to the molecular weight of
each protein of interest. These selections were analyzed to determine
pixel intensities of each lane. To normalize results, a horizontal
section of the Bio-Rad stain-free gel total protein image spanning a
broad molecular weight range was selected. Overall intensity was
determined for each lane, allowing for normalization without bias
toward a single representative loading control and taking into
account variability in tissue lysate extracts. Four animals from both
poly-GA149-CFP and wild-type animal cohorts were evaluated. For
each of these cohorts, two animals were male and two were female.
Immunohistochemistry
Following euthanasia in accordance with approved protocols, 20month-old mice were transcardially perfused with 1% sterile PBS.
Dissected spinal cord tissue was formalin-fixed for 2 days and paraffinembedded. Staining was performed on glass slides containing 10-lmthick sections cut from cervical and upper thoracic regions of these
tissue samples. Slides were heated to 55°C overnight, deparaffinized in
Histoclear, and rehydrated in sequential 100, 95, 90, and 70% ethanol
washes. Endogenous peroxidase activity was blocked by incubation in
3% hydrogen peroxide in methanol for 30 min. Antigen unmasking
was achieved through incubation in citrate target antigen retrieval solution at 95°C for 1 h. Sections were blocked in 10% normal goat serum
in PBS for 1 hour at room temperature. Slides were incubated overnight
at 4°C with primary antibodies against ChAT (Millipore Cat# AB144P,
RRID:AB_2079751, 1:1,000) and secondary labeling with AlexaFluor546 for motor neuron-specific staining. Hoechst was used to stain
nuclei. Slides were mounted in Citifluor AF3, and a Nikon A1+ microscope with NIS-Elements Imaging software was used for image capture
and processing. Motor neuron counts were achieved by a manual count
of motor neurons/anterior horn using ImageJ software. Number of
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The paper explained
Problem
A hexanucleotide repeat expansion in the C9orf72 gene is the most
common cause of familial and apparently sporadic cases of ALS. While
evidence has shown that loss-of-function haploinsufficiency of
C9orf72 protein levels may lead to immunological problems, gain-offunction toxic effects caused by accumulation of RNA foci and aggregates of dipeptide repeat proteins (DPRs) both resulting from aberrantly expanded RNA transcripts are the likely pathogenic culprits
behind the death of motor neurons. As many C9orf72 patients fall into
the sporadic ALS cohort, they possess a high DPR burden by the time
of diagnosis. The most abundant of these DPRs is the GA dipeptide,
which invokes very gradual cellular toxicity.
Results
Here, we show that mobile GA aggregates are present in the cytoplasm and axons of cortical and motor neurons. In functional studies,
we found that expression of GA resulted in increased Ca2+ influx but
reduced synaptic unloading in response to a stimulus for neuronal firing. Examination of synaptic proteins revealed that synaptic vesicleassociated protein 2 (SV2) was specifically reduced. While neurons
containing GA ultimately succumbed to toxicity, synaptic protein and
transmission deficits occurred several days prior to this demise.
Importantly, if we restore SV2 levels in GA-expressing cells, we are
able to successfully recover synaptic function and prevent neuronal
death. We validated reduction of SV2 in 20-month-old GA transgenic
mice, without loss of motor neurons. Finally, we confirmed specific
loss of SV2 in C9orf72-ALS patient-derived induced cortical and motor
neurons.

EMBO Molecular Medicine

Statistical analysis
All statistical analyses were performed using Prism 8.0 software
(GraphPad). Differences between Kaplan–Meier survival curves
were assessed by the log-rank test, with hazard ratios also
performed to assess direct comparison between selected conditions.
Statistical significance for pairwise assessment of each time point in
synaptic unloading experiments was accomplished using the Sidak–
Bonferroni method. One-way ANOVA with post hoc Dunnett’s multiple comparison test, one-way ANOVA with uncorrected Fisher’s
LSD test, and unpaired t-tests with Welch’s correction were
performed where indicated. All data are expressed as mean  SEM,
with values of P < 0.05 considered significant.

Data availability
No large scale data sets have been generated in this study.
Expanded View for this article is available online.
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male and three were female.
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